Therapeutic Area Head, Oncology
Novartis
This listing was originally posted on Novartis's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moJob Description Summary
As the Therapeutic Area Head, Oncology, you will lead one of the organization's most strategic and high-growth therapeutic areas, with full accountability for commercial performance, portfolio strategy, and organizational leadership. You will drive the development and execution of innovative business strategies that accelerate growth, maximize patient impact, and strengthen market leadership across the oncology portfolio. Working in close partnership with regional, country, and cross-functional teams, you will lead product launches, shape future portfolio opportunities, and develop a high-performing commercial organization capable of delivering sustainable business success in a rapidly evolving healthcare environment.
Job Description
Skills Desired
Asset Management, Business Development, Commercial Excellence, Cross-Functional Collaboration, Digital Marketing, Influencing Skills, Inspirational Leadership, Key Account Management, Market Access, Market Share, Market Trends, People Management, Product Launches, Product Lifecycle Management (PLM), Profit and Loss (P&L), Sales, Stakeholder Engagement, Stakeholder Management, Value PropositionsExplore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Novartis?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Small Molecules, Vaccines, Biologics / Diagnostics
Upgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo